Treatment of B cell diseases using antigermline antibody binding agents

Details for Australian Patent Application No. 2006292132 (hide)

Owner Palingen, Inc.

Inventors Sanders, Martin E.

Agent Spruson & Ferguson

Pub. Number AU-A-2006292132

PCT Pub. Number WO2007/035857

Priority 60/718,796 19.09.05 US

Filing date 19 September 2006

Wipo publication date 29 March 2007

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/035857 Priority application(s): WO2007/035857

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006292147-Tdf-related compounds and analogs thereof

2006292131-Systems for detection and production of respiratory, herpes and enteric viruses